UDG Healthcare Public Limited Co.

16 January 2017

UDG Healthcare plc

Notice of Q1 2017 Trading Update

UDG Healthcare plc ('UDG Healthcare' or 'Group'), a leading international healthcare services provider, will issue a trading update for the first quarter to 31 December 2016 at 7.00am (GMT) on Tuesday, 7 February 2017.

The Company will also host a conference call for investors and analysts at 9.00am (GMT) on Tuesday, 7 February 2017 to discuss the statement. The dial-in details are as follows:

Standard International Access

+44 (0) 20 3003 2666

UK Toll Free

0808 109 0700

Ireland

+353 (0) 1 436 0959

Password

UDG Healthcare

A playback facility will be available for seven days on +44 (0) 20 8196 1998. The access code for the replay will be 4565150#.

For further information, please contact:

Keith Byrne

Head of Investor Relations, Strategy & Corporate Communications

UDG Healthcare plc

Tel: +353-1-468-9000

Lisa Kavanagh / Jack Hickey / Nick Brown

Powerscourt

Tel: +44-207-250-1446

Email:udghealthcare@powerscourt-group.com

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering commercial, clinical, communications and packaging services to the healthcare industry, employing almost 8,000 people with operations in 23 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.

Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across two broad areas of activity: commercial & clinical services, and communications services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe. Sharp is also a world leader in 'Track and Trace' serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability.

Aquilant is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information please go to: www.udghealthcare.com

UDG Healthcare plc published this content on 16 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 16 January 2017 07:05:10 UTC.

Original documenthttp://otp.investis.com/clients/uk/udg_healthcare/rns/regulatory-story.aspx?cid=683&newsid=835610

Public permalinkhttp://www.publicnow.com/view/9881F3E78573117642D47E017ECBA28A0C5C76EC